Clinical Trials Directory

Trials / Completed

CompletedNCT02951442

Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the First Year of Renal Transplant

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
117 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to show that the contribution of Klotho by the renal graft is an independent determinant of the evolution of the recipient's central arterial stiffness during the first year of renal transplant. The contribution of Klotho by the graft will be estimated by: its circulating concentrations assay, its urinary excretion assay, and, indirectly, by the circulating concentrations of FGF23. The recipient's central arterial stiffness will be estimated by the measure of the carotid-femoral pulse wave velocity, noninvasive reference method for measuring aortic stiffness in human.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBiological sample
PROCEDURENon invasive Arterial investigations
PROCEDUREAbdominal tomodensitometry

Timeline

Start date
2011-01-01
Primary completion
2014-01-28
Completion
2014-01-28
First posted
2016-11-01
Last updated
2018-02-22

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02951442. Inclusion in this directory is not an endorsement.

Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the First Yea (NCT02951442) · Clinical Trials Directory